K2 Principal Fund, L.P. Annexon, Inc. Transaction History

K2 Principal Fund, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$4.56 - $6.61 $438,822 - $636,100	96,233 Added 195.08%	145,564 $752,000
Q3 2022 Nov 14, 2022	SELL	$3.75 - $6.63 $1.3 Million - $2.3 Million	-347,026 Reduced 87.55%	49,331 $305,000
Q2 2022 Aug 12, 2022	BUY	$2.11 - $4.06 $836,313 - $1.61 Million	396,357 New	396,357 $1.49 Million

158

102M

3.61M

1.08M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $312M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.